Danaher Corporation (DHR) Fundamentals

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
SHARE INFORMATION
Market Cap$ 211,788,440,655
Shares Outstanding727,445,355
Float648,708,724
Percent Float89.18%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.84
Latest Fiscal Revenue$ 29,453,000,000
Latest Fiscal EPS$ 8.62
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 8.76
Dividend (5 Years)$ 8.85
Ex Dividend Date2022-06-23
Dividend Rate$ 1.00
Dividend Yield0.34%
Payment CashCash
HOLDERS
Institutions3,611
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months40,732,156
Institutional Holdings Percent151.1%
Institutional Sold Previous 3 Months48,084,807
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months39,291
Insider Holdings Percent0.6
Insider Sold Previous 3 Months22,043
Insider Shares Owned4,056,001
TRADING INFO
52 Week High$ 333.96
52 Week Low$ 233.71
52 Week High Change$ -5.44
21 Day Moving Average$ 275.3095
21 Day Extended Moving Average$ 278.6079
50 Day Moving Average$ 263.9048
50 Day Extended Moving Average$ 269.5419
200 Day Moving Average$ 280.8526
200 Day Extended Moving Average$ 272.6598
10 Day Average Volume1,815,704
20 Day Average Volume2,235,321
30 Day Average Volume2,069,791
50 Day Average Volume2,277,808
Alpha0.015509
Beta0.8646
Standard Deviation0.066598
R20.421634
7 Day Price Change$ 2.61
7 Day Percent Change0.9%
21 Day Price Change$ 35.14
21 Day Percent Change13.73%
30 Day Price Change$ 27.38
30 Day Percent Change10.38%
Month to Date Price Change$ -0.33
Month to Date Percent Change-0.11%
Quarter to Date Price Change$ 37.62
Quarter to Date Percent Change14.84%
180 Day Price Change$ 9.47
180 Day Percent Change3.36%
200 Day Price Change$ 11.22
200 Day Percent Change4.01%
Year to Date Price Change$ -37.25
Year to Date Percent Change-11.34%

Danaher Corporation (DHR) Key Ratios

PROFITABILITY
EBIT Margin25.5%
EBITDA Margin32.8%
Pre-Tax Profit Margin19.4%
Profit Margin Count20.67%
Gross Margin60.8%
Profit Margin TOT20.68%
INCOME STATEMENTS
Revenue$ 30,816,000,000
Revenue Per Share$ 42.3619
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-13.60
Total Debt To Equity0.50
Int Coverage35.30
Current Ratio1.80
Leverage Ratio1.90
Quick Ratio1.10
Long Term Debt To Capital0.30
VALUATION MEASURES
PE Ratio33.60
Enterprise Value$ 225,242,513,060
Price to Sales6.8727
Price to Free Cash-55.90
PE High Last 5 Years68.40
Price To Book4.60
Price To Cash Flow25.20
PE Low Last 5 Years21.30
Price to Tangible Book-13.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover7.40
Invoice Turnover4.40
Assets Turnover0.40
Return Assets8.23
Return on Equity15.55
Return on Capital10.23

Danaher Corporation (DHR) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEORainer M. Blair
Emplyoees80000
Last AuditUQ
CIK0000313616
IndustryMedical Diagnostics & Research
SectorHealthcare
NAICSMedical Laboratories(621511)
CONTACT INFO
Address2200 Pennsylvania Avenue, North West
Suite 800W
Washington, DC 20037-1701
Websitehttps://www.danaher.com
Facsimile+1 202 828-0860
Telephone+1 202 828-0850
Emailinvestor.relations@danaher.com


Your Recent History
NYSE
DHR
Danaher
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.